#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Precursor T-lymphoblastic lymphoma/leukaemia recurrent Superficial vein thrombosis Small cell lung cancer limited stage IPEX syndrome Adrenogenital syndrome Anal fistula Congenital absence of bile ducts Angelman's syndrome Myelofibrosis Squamous cell carcinoma of the cervix Non-renal cell carcinoma of kidney Henoch-Schonlein purpura nephritis Neuronal ceroid lipofuscinosis Prostate cancer Microvillous inclusion disease More trials…

    Learn about Rare Diseases

    Angiosarcoma recurrent Prolymphocytic leukaemia – Life with Disease Progressive multifocal leukoencephalopathy – Treatment Progressive multifocal leukoencephalopathy – Basic Information Primary hyperoxaluria – Basic Information Prader-Willi syndrome – Basic Information Progressive multifocal leukoencephalopathy Breast angiosarcoma – Treatment Progressive multifocal leukoencephalopathy – Diagnostics Langerhans’ cell histiocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Al8326 [18F] CANAGLIFLOZIN Irbesartan USNOFLAST Ddcart‐Cd19 N-Tec Blood And Related Products MAGNESIUM ACETATE TETRAHYDRATE Lutetium (177Lu)-Neobomb1 Gadoteric Acid VERCIRNON Magnesium Sulfate INOBRODIB Mercaptopurine Eletriptan Omeprazole Tebipenem Pivoxil Hydrobromide Lactose Monohydrate 177Lu-Dpi-4452 Glatiramer Acetate More therapies…

    Learn about Your Condition

    Nephrotic syndrome Renal disorder Carcinoid syndrome Vascular graft thrombosis Myopia Craniosynostosis Hypochondroplasia Compulsive sexual behaviour Radicular pain Cerebral haemorrhage Bronchopulmonary aspergillosis Muscle injury Lymphangioleiomyomatosis Colorectal adenocarcinoma Precocious puberty More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of BCG Vaccine and Sodium Chloride for Patients with Radiologically Isolated Syndrome (RIS)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Radiologically isolated syndrome
    Investigated Drugs:
    • Live Bcg Bacilli (Bacillus Calmette-Guerin), Brasilian Moreau Substrain
    • Sodium Chloride
    Italy

  • Study on the Effect of Metyrapone on Heart Health in Patients with Adrenal Tumors and Mild Cushing’s Syndrome

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Metyrapone
    Italy

  • Study on Cisplatin, Nab-paclitaxel, and Nivolumab with Radiotherapy for Patients with Non-Metastatic Muscle Invasive Bladder Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Cisplatin
    • Nivolumab
    • Paclitaxel Albumin-Bound
    Italy

  • Study on the Effectiveness of Paclitaxel and Gemcitabine for Patients with Pancreatic Cancer Spread to the Abdomen

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Gemcitabine
    • Paclitaxel
    Italy

  • Study on 68Ga-FAPI-46 PET/CT for Cancer Patients with Unclear Results from 18F-FDG PET/CT

    Recruiting

    2 1 1
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    Italy

  • Study on Antibiotics Amoxicillin, Clavulanic Acid, Ciprofloxacin, and Drug Combination for Children with Malignant Brain Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Brain neoplasm
    Investigated Drugs:
    • Cefotaxime Sodium
    • Cefuroxime Sodium
    • Gentamicin
    Austria
Previous Page
1 … 293 294 295 296 297 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!